In this report, we identify APPL1 as a TβRI- and PKCζ-associated protein and show that APPL1 and APPL2 are required for the nuclear translocation of TβRI-ICD, and thereby promote progression of prostate cancer cells. Here, TGFBR1 is linked to prostate carcinoma.